EIF2A and neoplasm: The anti-tumor function of sustained eIF2α-P is supported by a previous study showing that disruption of the acinar morphogenesis of human epithelial MCF10A cells by HER2 in 3D cultures is prevented by treatment by the eIF2-phosphatase inhibitor Salubrinal53.